C4V8L1 AF NFT

Probable leucine--tRNA ligase, cytoplasmic

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigfnq3vvkgglhg6tynq3oygdbhqdwkimjhlqmiausuyty66vxtuum/metadata.json
IPFS of structure file: 
bafybeigi5mgxowmkpfervivxorgax5musuplmukqk3wcu56blg7p6c6yke/AF-C4V8L1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x738c1929c69B751bD0Be0B962D9bac20B631aAc6
First NFT owner address (bech32): 
genesis1wwxpj2wxnd63h597pwtzmxavyzmrr2kx0xhph5
Current NFT ID #449779 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449779
Accession (UniProt):
C4V8L1
Name::
Probable leucine--tRNA ligase, cytoplasmic
Experimental Method:
Predicted structure
Sequence source:
Nosema ceranae (strain BRL01)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C4V8L1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C4V8L1|SYLC_NOSCE Probable leucine--tRNA ligase, cytoplasmic OS=Nosema ceranae (strain BRL01) OX=578460 GN=NCER_100842 PE=3 SV=1 MNCNEHESTKLNYLNSLEKSRDVKTDISDKPKYFITFPYPYMNGKLHLGHLYSISKADFMSYYKELQGFNVLFPLAFHCTGMPIAALAKKLGEELEGKKTDISTKEIIQNLGFNDVMPFTDPVHWIKTFPKLCISSLKTFGANIDWRRSFVTTDINKYYDSFVRWQFFNLKELGYLSFGKRHSIYCPLDKQMCLDHDRRKGENIKPVRQIMFKFHLHDKILLVRQNSIGKPYKLVCGKSLEVVSFKYNNTSFLAEKIIFDNLKYQINNVKYKESLVLSMDLKDGLTYDGTNIEVEVIEKNILVVKTDTKSDVELYEKEIKALNEIEETLFTLSTSSEGIVESVAKLSVENTKDLLVQTKHFISVYIPEKEVISRSGGICVVSLLDQWYIDYSNEKWKSKVKKCLDNLECGPDTRSMLYAGIDWVNKWGFSRSFGLGTKIPWDTQYLIDSLSDSTIYMAFYTVKHLLFEDLEGKLEIFPSNKLSNDVWDYIFAGKDLVPELYGYLDLLEKCRNNFQYFYPVDLRVSGKDLIKNHLLFFMFNHVALFDEKYWPKRIFTNGHLMLNKEKMSKSTGNFLSVDDALLKYGKSATRMCLAVCGDTNDDANFVEDNANLFILKIYTFVKEIQKLNELVRKKSENETIASYSNADVLLLETVSVNVTEALNAYNSMKYSDVVKFSFFEMVNLINLYNNINGTNILLKNLVYKSATQLLYPIMPDLCRTLIEKYFDSEFNLPEPKLKTNKMISAFEYISELIKKIAASKQAKNNSCVKIAVGKNYSEWKKEIFELIDKIDCPRNNEIKKNKVFIASLLDSVKPILQKSKINITKGNNFVMDYLVNPDKFVMKFNEYEIINEFKFYIENMSNKKAILEEHCDAEPLNPIITFSK